A nutritional therapy (neurotransmitter precursors supplements ) for heroin addiction recovery

Research of neurotransmitters and psychology energy supply model on drug relapse prevention

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10000803

Enrollment

Unknown

Registered

2010-03-15

Start date

2009-10-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heroin addiction

Interventions

Group A:L-tyrosine, glutamate, 5-hydroxytryptophan and lecithin

Group B:Placebo (glucose tablets)

Eligibility

Sex/Gender

Male

Age

20 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Male; 2. 20-55 years old; 3. Heroin dependence as assessed by DSM-IV; 4. Detoxified for 7 days; 5. Able and willing to provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Schizophrenia, psychosis or organic mental disorder by DSM-IV criteria; 2. Substance dependence other than heroin; 3. Heart, liver, kidney, and other major organ dysfunction; 4. Hematopoietic and endocrine system diseases; 5. The score of Athens Insomnia Scale<4; 6. Unable or unwilling to perform treatment following the research schedule; 7. Any other unsuitable reasons for the trial.

Design outcomes

Primary

Measure	Time frame
Protracted Withdrawal Symptoms Scale for Heroin Addicts (PWSSHA);Athens Insomnia Scale (AIS);	—

Secondary

Measure	Time frame
Profile Of Mood States (POMS);	—

Countries

China

Contacts

Public ContactZengzhen Wang

wzzh@mails.tjmu.edu.cn+86 027 83657775

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026